These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 18203097)

  • 1. Hyperthyroidism and severity of orbital disease do not change the central corneal thickness in Graves' ophthalmopathy.
    Konuk O; Aktas Z; Aksoy S; Onol M; Unal M
    Eur J Ophthalmol; 2008; 18(1):125-7. PubMed ID: 18203097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperthyroidism and severity of orbital disease do not change the central corneal thickness in Graves'' ophthalmopathy.
    Unal M; Onol M; Konuk O; Aktas Z; Aksoy S
    Eur J Ophthalmol; 2008; 18(1):125-127. PubMed ID: 28221500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease.
    Noh JY; Hamada N; Inoue Y; Abe Y; Ito K; Ito K
    Thyroid; 2000 Sep; 10(9):809-13. PubMed ID: 11041459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A clinico-investigative profile in Graves' ophthalmopathy.
    Khurana AK; Sunder S; Ahluwalia BK; Malhotra KC; Gupta S
    Indian J Ophthalmol; 1992; 40(2):56-8. PubMed ID: 1452284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of Grave's ophthalmopathy with high doses of corticosteroids].
    Cirić J; Zarković M; Stojanović M; Pepenezić Z; Randjelović G; Gligorović M; Trbojević B; Drezgić M; Nesović M
    Srp Arh Celok Lek; 2000; 128(5-6):179-83. PubMed ID: 11089418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Orbital Decompression on Corneal Topography in Patients with Thyroid Ophthalmopathy.
    Kim SA; Jung SK; Paik JS; Yang SW
    PLoS One; 2015; 10(9):e0133612. PubMed ID: 26352432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe Graves' ophthalmopathy after percutaneous ethanol injection in a nontoxic thyroid nodule.
    Regalbuto C; Le Moli R; Muscia V; Russo M; Vigneri R; Pezzino V
    Thyroid; 2012 Feb; 22(2):210-3. PubMed ID: 22196093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Childhood Graves' ophthalmopathy: results of a European questionnaire study.
    Krassas GE; Segni M; Wiersinga WM
    Eur J Endocrinol; 2005 Oct; 153(4):515-21. PubMed ID: 16189172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum immunoglobulin G4 levels and Graves' disease phenotype.
    Martin CS; Sirbu AE; Betivoiu MA; Florea S; Barbu CG; Fica SV
    Endocrine; 2017 Feb; 55(2):478-484. PubMed ID: 27819113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Graves' ophthalmopathy in the absence of elevated free thyroxine and triiodothyronine levels: prevalence, natural history, and thyrotropin receptor antibody levels.
    Khoo DH; Eng PH; Ho SC; Tai ES; Morgenthaler NG; Seah LL; Fong KS; Chee SP; Choo CT; Aw SE
    Thyroid; 2000 Dec; 10(12):1093-100. PubMed ID: 11201855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of thyroid hormone status on selected antioxidant parameters in patients with Graves' disease and active thyroid-associated orbitopathy.
    Londzin-Olesik M; Kos-Kudła B; Nowak A; Wielkoszyński T; Nowak M
    Endokrynol Pol; 2020; 71(5):418-424. PubMed ID: 32797475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraocular pressure lowering effect of orbital decompression is related to increased venous outflow in Graves orbitopathy.
    Onaran Z; Konuk O; Oktar SÖ; Yücel C; Unal M
    Curr Eye Res; 2014 Jul; 39(7):666-72. PubMed ID: 24502333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corneal astigmatism in Graves' ophthalmopathy.
    Mombaerts I; Vandelanotte S; Koornneef L
    Eye (Lond); 2006 Apr; 20(4):440-6. PubMed ID: 15846381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroid volume and severity of Graves' orbitopathy.
    Profilo MA; Sisti E; Marcocci C; Vitti P; Pinchera A; Nardi M; Rocchi R; Latrofa F; Menconi F; Altea MA; Leo M; Rago T; Marinò M
    Thyroid; 2013 Jan; 23(1):97-102. PubMed ID: 23088654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum concentrations of adiponectin and resistin in hyperthyroid Graves' disease patients.
    Sieminska L; Niedziolka D; Pillich A; Kos-Kudla B; Marek B; Nowak M; Borgiel-Marek H
    J Endocrinol Invest; 2008 Sep; 31(9):745-9. PubMed ID: 18997483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Latanoprost is effective in reducing high intraocular pressure associated with Graves' ophthalmopathy.
    Gumińska M; Kłysik A; Siejka A; Jurowski P
    Klin Oczna; 2014; 116(2):89-93. PubMed ID: 25345284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low response of the thyroid gland to endogenous thyrotropin increased by thyrotropin-releasing hormone in patients with euthyroid Graves' disease.
    Kashiwai T; Tada H; Watanabe Y; Shimaoka Y; Yagoro A; Hidaka Y; Fujikado T; Amino N
    Thyroid; 1998 Oct; 8(10):881-5. PubMed ID: 9827654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corneal involvement in Graves' orbitopathy: an in vivo confocal study.
    Villani E; Viola F; Sala R; Salvi M; Mapelli C; Currò N; Vannucchi G; Beck-Peccoz P; Ratiglia R
    Invest Ophthalmol Vis Sci; 2010 Sep; 51(9):4574-8. PubMed ID: 20435595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: results of a prospective, single-blind, randomized study.
    Marcocci C; Bartalena L; Tanda ML; Manetti L; Dell'Unto E; Rocchi R; Barbesino G; Mazzi B; Bartolomei MP; Lepri P; Cartei F; Nardi M; Pinchera A
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3562-7. PubMed ID: 11502779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicotinamide phosphoribosyltransferase leukocyte overexpression in Graves' opthalmopathy.
    Sawicka-Gutaj N; Budny B; Zybek-Kocik A; Sowiński J; Ziemnicka K; Waligórska-Stachura J; Ruchała M
    Endocrine; 2016 Aug; 53(2):497-504. PubMed ID: 26767650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.